Status:
UNKNOWN
Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）
Lead Sponsor:
Chinese Academy of Medical Sciences
Conditions:
Complications of Organ Transplant Stem Cells Umbilical Cord
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
Mesenchymal Stem Cells (MSC) is a non Hematopoietic Stem Cells (HSC) in adult bone marrow and takes part in the bone marrow microenvironment. The response rate of early treatment on Children's SAA app...
Detailed Description
1. Mesenchymal Stem Cells were prepared by in vitro separation, screening, and culture from healthy human umbilical cord tissue; The " injection of mesenchymal stem cells (umbilical) manufacturing and...
Eligibility Criteria
Inclusion
- Non-Severe Aplastic Anemia (NSAA)atients
Exclusion
- Severe Aplastic Anemia (SAA) patients
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02218437
Start Date
October 1 2013
End Date
October 1 2015
Last Update
August 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences and Peking Union Medical College
Tianjin, China, 300020